Stocks
Funds
Screener
Sectors
Watchlists
MYO

MYO - Myomo Inc Stock Price, Fair Value and News

$0.86-0.08 (-8.51%)
Market Closed

78/100

MYO

STOCK SCORE

High Scoring Large Cap stocks have outperformed low scoring stocks by 90% over last 10 years

78/100

MYO

STOCK SCORE

High Scoring Large Cap stocks have outperformed low scoring stocks by 90% over last 10 years

Price Targets

Target 1Y

$1.36

Target 3M

$1.01

Target 6M

$1.13

MYO Stock Valuation Analysis

Valuation

Login to View

Max Portfolio %

Login to View

MYO Price Action

Last 7 days

-11.3%

Last 30 days

-6.5%

Last 90 days

-7.5%

Trailing 12 Months

-85.3%

MYO RSI Chart

MYO Stock Valuation Analysis

Valuation

Login to View

Max Portfolio %

Login to View

MYO Valuation

Market Cap

33.1M

Price/Earnings (Trailing)

-2.75

Price/Sales (Trailing)

0.79

EV/EBITDA

-2.12

Price/Free Cashflow

-2.39

MYO Price/Sales (Trailing)

The Good, Bad and Ugly

Growth

Profitability

Size

Dilution Risk

Balance Sheet

Momentum

Funds Popularity

Insider Trading

Price Targets

Target 1Y

$1.36

Target 3M

$1.01

Target 6M

$1.13

MYO Fundamentals

MYO Revenue

Revenue (TTM)

41.6M

Rev. Growth (Yr)

9.59%

Rev. Growth (Qtr)

4.54%

MYO Earnings

Earnings (TTM)

-12.0M

Earnings Growth (Yr)

-279.02%

Earnings Growth (Qtr)

20.92%

MYO Profitability

Operating Margin

66.56%

EBT Margin

-27.65%

Return on Equity

-82.18%

Return on Assets

-35.27%

Free Cashflow Yield

-41.89%

MYO Investor Care

Shares Dilution (1Y)

27.08%

Diluted EPS (TTM)

-0.28

Historical Charts for Stock Metrics

Get all data in R, Python etc through our Historical Stock Data APIs
Net sales
YearQ1Q2Q3Q4
202538.6M40.8M41.6M0
202419.5M21.1M25.2M32.6M
202315.1M17.4M18.5M19.2M
202215.4M16.0M15.5M15.6M
20218.9M11.2M13.6M13.9M
20204.0M4.0M5.3M7.6M
20193.0M3.2M3.2M3.8M
20181.7M2.0M2.1M2.4M
20171.2M1.3M1.4M1.6M
20160001.1M
MYO
Myomo, Inc., a wearable medical robotics company, designs, develops, and produces myoelectric orthotics for people with neuromuscular disorders in the United States, Germany, China, and internationally. The company offers MyoPro, a myoelectric-controlled upper limb brace or orthosis product used for supporting a patient's weak or paralyzed arm to enable and improve functional activities of daily living. Its products are designed to help improve function in adults and adolescents with neuromuscular conditions due to brachial plexus injury, stroke, traumatic brain injury, spinal cord injury, and other neurological disorders. The company sells its products to orthotics and prosthetics providers, the Veterans Health Administration, rehabilitation hospitals and surgery centers, as well as through distributors. Myomo, Inc. was incorporated in 2004 and is headquartered in Boston, Massachusetts.
 CEO
 WEBSITEhttps://myomo.com
 SECTORHealthcare
 INDUSTRYMedical Devices
 EMPLOYEES100

Myomo Inc Frequently Asked Questions


MYO is the stock ticker symbol of Myomo Inc. Every public company that trades on a stock exchange gets a ticker symbol.

As of Wed Jan 28 2026, market cap of Myomo Inc is 33.05 Million. The market capitalization is calculated by multiplying the stock price with the number of shares outstanding.

You can check MYO's fair value in chart for subscribers.

The fair value guage provides a quick view whether MYO is over valued or under valued. Whether Myomo Inc is cheap or expensive depends on the assumptions which impact Myomo Inc's fair value. We provide several scenarios of inflation and growth to encompass these range of assumptions for MYO.

As of Wed Jan 28 2026, MYO's PE ratio (Price to Earnings) is -2.75 and Price to Sales (PS) ratio is 0.79. The price to earnings and price to sales ratio are two most important valuation metrics for any company. PE ratio tell us the number of years of earnings investors are ready to pay for owning the company. Historically, S&P500 price to earnings ratio has fallen below 12 during periods of gloom and gone past 30 during periods of euphoria. MYO PE ratio will change depending on the future growth rate expectations of investors.